Over the past 12‑18 months, the Zinc Citrate Dihydrate market has experienced a cascade of strategic moves that are reshaping the competitive landscape. In early 2024, NutrientCo partnered with Swiss biotech firm HelixBio to co‑develop a high‑purity, nano‑encapsulated Zinc Citrate Dihydrate aimed at fortified beverages, accelerating time‑to‑market for clean‑label products. Meanwhile, US‑based Elemental Minerals acquired Canadian supplier PureZinc for $85 million, consolidating North American supply chains and expanding capacity by 30 %. The same quarter, GreenPharm launched its first “Zinc‑Boost” oral supplement featuring a patented slow‑release Zinc Citrate Dihydrate matrix, targeting senior health segments. Regulatory momentum also intensified: the European Food Safety Authority revised the maximum allowable daily intake, prompting manufacturers to reformulate and label more transparently. Consumer demand for immune‑support and sustainable sourcing has pushed enterprises toward bio‑based production routes, while a $45 million Series B round led by EcoCap enabled a new plant in India to double output by 2025. These Zinc Citrate Dihydrate industry trends signal heightened consolidation, innovation, and regulatory alignment.